Details for New Drug Application (NDA): 209869
✉ Email this page to a colleague
NDA 209869 describes PRAVASTATIN SODIUM, which is a drug marketed by Accord Hlthcare, Apotex, Aurobindo Pharma, Aurobindo Pharma Usa, Biocon Pharma, Chartwell Rx, Cipla, Dr Reddys Labs Inc, Glenmark Pharms Ltd, Hisun Pharm Hangzhou, Pharmobedient, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Senores Pharms, Watson Labs, and Zydus Pharms Usa, and is included in eighteen NDAs. It is available from thirty-seven suppliers. Additional details are available on the PRAVASTATIN SODIUM profile page.
The generic ingredient in PRAVASTATIN SODIUM is pravastatin sodium. There are sixteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.
The generic ingredient in PRAVASTATIN SODIUM is pravastatin sodium. There are sixteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.
Summary for 209869
| Tradename: | PRAVASTATIN SODIUM |
| Applicant: | Biocon Pharma |
| Ingredient: | pravastatin sodium |
| Patents: | 0 |
Pharmacology for NDA: 209869
| Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for 209869
Suppliers and Packaging for NDA: 209869
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 209869 | ANDA | A-S Medication Solutions | 50090-7612 | 50090-7612-0 | 30 TABLET in 1 BOTTLE (50090-7612-0) |
| PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 209869 | ANDA | A-S Medication Solutions | 50090-7612 | 50090-7612-1 | 90 TABLET in 1 BOTTLE (50090-7612-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 13, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
| Approval Date: | Apr 13, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
| Approval Date: | Apr 13, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
